Mega Events in September Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Aware...(g! -- Cholesterol Screenings Mason Pa...),Health
Navigation Links
Mega Events in September Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month
Date:9/4/2007
g! -- Cholesterol
Screenings Mason Park
541 S 75th Street
Houston, TX 77023
Thousands are expected to attend this event.
**CHICAGO, ILLINOIS**
MEGA EVENT
Saturday and Sunday, September 15-16, 2007
12:00 pm -- 6:00 pm
Festival de la Villita -- Cholesterol Screenings
Health Supersite -- 26th and Kostner, Little Village
Chicago, IL
Thousands are expected to attend this event.
**MIAMI, FLORIDA**
Friday, September 14, 2007
9:30 AM - 1:00 PM
Little Havana Cholesterol Screening Day
Rafael Villaverde Senior Center
700 SW 8th Street,
Miami, Florida 33130
Wednesday, September 19, 2007
9:30 AM - 1:00 PM
Little Havana Cholesterol Screening Day
Myers Senior Center
450 SW 5th Street
Miami, Florida 33135
Contact: Adam J. Segal, 202-422-4673 or adam@the2050group.com
'/>"/>
| SOURCE National Alliance for Hispanic Health Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Breast Feeding prevents obesity later on in life
2. Regular exercise prevents hip fractures
3. Gel prevents pregnancy
4. Handwashing prevents diarrhea and acute lower respiratory infections
5. Staying mentally energitic prevents Alzheimers
6. Consuming fish prevents dementia risk
7. Cardiac events better treated with intense cholesterol-lowering regime
8. Tea Prevents Skin Cancer
9. Research unearths how caffeine prevents us from sleeping
10. Use Of Sunscreen In Childhood And Prevents Future Skin Cancer
11. Research Shows Carbon Monoxide Prevents Inflammations
Post Your Comments:
(Date:12/4/2008)...Discrimination Safeguards to Ensure Patient Access...ire-USNewswire/ -- The American Optometric Associa...e providers of eye and vision care in America, and...s, Access to Responsible Care Alliance (PARCA) tod...ressional leaders to support legislation to increa...
(Date:12/4/2008)...BAPTIST HEALTH, a six-hospital,system based in Li...stem, has,expanded its use of Clinical Xpert(TM) ... enabled the system,s pharmacists to increase nece...1 million. , "Data we collected for the 220... prompts approximately half of the pharmacy clinic...
(Date:12/4/2008)...io study of 491 women with invasive ovarian cancer... for genetic testing of BRCA1 and BRCA2, the breas... informed of their cancer risk. , Dr. Kelly Met... Toronto,s Lawrence S. Bloomberg Faculty of Nursin...earch Institute, led the nursing study, which was ...
(Date:12/4/2008)...and on the eve of its 35th Anniversary, Ronald McD...ated Season of Giving marketing campaign to remind... initiative, designed to drive personal donations,... three core programs: Ronald McDonald House, Ronal...e Mobile. , OAK BROOK, I...
Breaking Medicine News(10 mins):Health News:AOA-Led Group Urges Obama to Increase Health Care Access, Affordability by Combating Provider Discrimination 2Health News:AOA-Led Group Urges Obama to Increase Health Care Access, Affordability by Combating Provider Discrimination 3Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 3Health News:Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 3[0] AOA-Led Group Urges Obama to Increase Health Care Access, Affordability by Combating Provider Discrimination[0] BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy[0] Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes[0] Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times
...kungunya and dengue fever in the state has been br...Aedes aegypti, mosquito is the common carrier of b...irus. Hence, the state has taken up an integrated ...000 health workers and volunteers. All the water s...
...ed that extreme and prolonged stress could lead to... to switch off, could lead to grave health problem...und that not being able to sleep is a top worry fo...g with every day life. They are not so much concer...
...d on the street, causes the abnormal buildup of pr...ng heart enlargement that can ultimately lead to s...y of South Florida College of Medicine and James A... was published in the July 2006 issue of the Journ...
... eight times more likely to injure their knee's an...nterparts, according to a recent study led by Morg...terian and Columbia University Medical Center. Pub..., the study looks at the reasons why the knee inju...
Other Medicine News:Health News:Researchers Identify Key Step in Cocaine-Induced Heart Enlargement, Sudden Death 2Health News:Adolescent Girl Athletes More Likely to Injure Knees Than Boys 2(Date:12/4/2008)...lif., Dec. 4 Thoratec Co...vice-based mechanical circulatory support,therapi...id today that a,pre-specified interim analysis of...DT) pivotal trial shows that patients implanted wi...comes versus those in the control group who,were ...
(Date:12/4/2008)...ember 4 Biopharmaceutical company ...fully completed treatment of the,last patient on ...a donor,lymphocyte cell based product, is under d...ease (GvHD) and allow early immune reconstitution ...n. Nineteen end stage blood cancer,patients were ...
(Date:12/4/2008).... 4 NovaRx Corporation announced t...to the position of President and Chief Operating O...an 25 years experience in drug discovery and a lon...eutical discovery and development. He also has ex...panies developing pioneering new technologies. Pr...
(Date:12/3/2008)...t-line data demonstrating potential in newly diagn...emia to be featured in two oral sessions at ASH ,...for chronically transfused patients by significant..., , - New long-term data from major indepen...imal post-surgery treatment strategy, Femara vs. t...
Breaking Medicine Technology:Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 2Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 3Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial 4Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations 2NovaRx Appoints Industry Veteran as President and COO 2NovaRx Appoints Industry Veteran as President and COO 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Bristol Myers Squibb Board Elects James M Cornelius Chairman of the Board 3224 1Bristol Myers Squibb Board Elects James M Cornelius Chairman of the Board 3224 2Breakthrough in pre eclampsia test 11643 1Breakthrough in pre eclampsia test 11643 2Nfocus Neuromedical Receives CE Mark for the CardioVasc 28TM 29 Stent Graft and Delivery System 11639 1Nfocus Neuromedical Receives CE Mark for the CardioVasc 28TM 29 Stent Graft and Delivery System 11639 2MBF Healthcare Acquisition Corp and Critical Homecare Solutions Holdings Inc to Present at the 2008 UBS Healthcare Services Conference 3221 1MBF Healthcare Acquisition Corp and Critical Homecare Solutions Holdings Inc to Present at the 2008 UBS Healthcare Services Conference 3221 2MBF Healthcare Acquisition Corp and Critical Homecare Solutions Holdings Inc to Present at the 2008 UBS Healthcare Services Conference 3221 3[0] Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial[0] Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations[0] NovaRx Appoints Industry Veteran as President and COO[0] More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
...-Apr 26, 2007 - Northfield,Laboratories Inc. (Nasd...ch organization has informed the Company that the ...III trauma trial with,PolyHeme(R), the Company,s h...stitute, will not be complete until May., About No...c. is a leader in developing an,oxygen-carrying re...
...monstrates dramatic,benefits of adding Diovan to c...o superior outcomes for,Diovan patients , , , B...from the independent,Jikei Heart Study, published ... pressure lowering medication Diovan® to,conve...in,cardiovascular events and a 40% reduction in st...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Straight 21 mm serrated jaws. Ring handle with ratchet lock. Non-magnetic and dull finish. Overall length 4.8 inches.
Shafts angled 45 degrees with 10 mm jaws. Serrated handle with polished finish. Smooth jaws. Most popular size or model.
Straight shafts with 16 mm long platform. Lengthwise serrated jaws with cross serrated tips. Serrated handle with polished finish. Platform: 2.4 mm wide.
Straight shafts with 6.5 mm tying platform. Crisscross serrated 1mm tips. Scalloped handle with dull finish.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |